Error loading player: No playable sources found
Session IV: New Technologies, Approaches, and Methods
Date
September 12, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Session Chairs: Ingo Lindner, Roche Diagnostics GmbH and Hillary Schuessler, Merck & Co., Inc.
Session Speakers:
Advanced MS-based Technologies to Tackle Characterization Challenges of Complex Formats and New Modality Biotherapeutics
Feng Yang, Genentech, A Member of the Roche Group
High-throughput Screening Strategies to Characterize Protein Conjugation
Anumita Saha, Merck & Co., Inc.
Use of Multi-Attribute Methods for In-Process Monitoring and Quality Control of Complex Biologics
Anita Liu, Merck & Co., Inc.
Session Chairs
Speakers
Related Products
Diverse Voices: Breakfast Session
Diversity is not a _color. _It is who is represented in the workplace, research, and society. Examples include gender diversity, age diversity, ethnic diversity, physical ability and neurodiversity…
Session VIII: MAM for Product & Process Characterization & Quality Control
Session Chairs: Ingo Lindner,_ Roche Diagnostics GmbH_ and Da Ren, _BioTherapeutics Solutions_
Session III: Joint MS/HOS Plenary Session: Mass Spec Technologies in HOS / Comprehensive Toolboxes for Complex Problems
Session Chair: Frances Namuswe, _CDER, FDA_
Session IX: Multi-Omics in Process Development
Session Chairs: Chris Chumsae, _Bristol-Myers Squibb Company _and Andrew Mahan, _Johnson & Johnson Innovative Medicine _
